ArticleJournal of medicine and life2024
The impact of empagliflozin and metformin on cardiac parameters in patients with mid-range ejection fraction heart failure without diabetes.
Reeman Sabbar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.